Antiretroviral therapy initiation in France: adherence to national guidelines and outcome.

Vatthanaphone Latthaphasavang, Marie-Anne Bouldouyre, Anne Rachline, Diane Ponscarme, Willy Rozenbaum, Jean-Yves Mary, Constance Delaugerre, Jean-Michel Molina
{"title":"Antiretroviral therapy initiation in France: adherence to national guidelines and outcome.","authors":"Vatthanaphone Latthaphasavang,&nbsp;Marie-Anne Bouldouyre,&nbsp;Anne Rachline,&nbsp;Diane Ponscarme,&nbsp;Willy Rozenbaum,&nbsp;Jean-Yves Mary,&nbsp;Constance Delaugerre,&nbsp;Jean-Michel Molina","doi":"10.1177/1545109711418362","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives and methods: </strong>Retrospective study of all patients who started antiretroviral therapy (ART) in 2007 in a single center in Paris, with baseline characteristics and 1-year outcome, to assess adherence to national guidelines.</p><p><strong>Results: </strong>We analyzed 118 patients. Time of ART initiation was in agreement with the guidelines for only 64 (54.2%) patients. Fifty patients (42%) started ART with AIDS or a CD4 count <200 cells/mm(3). In all, 62 (52%) and 47 patients (40%) received a combination of 2 nucleoside analogues with efavirenz (EFV) and 1 ritonavir-boosted protease inhibitor (PI/r), respectively. Treatment regimens were in accordance with the guidelines for 114 patients (97%). At 1 year, 16 patients (13.5%) were lost to follow-up, only 5 (4.9%) experienced HIV disease progression or death, but 19 (18.6%) required hospitalization. Antiretroviral therapy was changed in 21 patients (21%). Ten patients (8.4%) experienced virologic failure.</p><p><strong>Conclusion: </strong>Antiretroviral therapy was in agreement with guidelines for the choice of combination but was often initiated too late.</p>","PeriodicalId":86092,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)","volume":"11 1","pages":"40-6"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109711418362","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1545109711418362","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2011/8/31 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Objectives and methods: Retrospective study of all patients who started antiretroviral therapy (ART) in 2007 in a single center in Paris, with baseline characteristics and 1-year outcome, to assess adherence to national guidelines.

Results: We analyzed 118 patients. Time of ART initiation was in agreement with the guidelines for only 64 (54.2%) patients. Fifty patients (42%) started ART with AIDS or a CD4 count <200 cells/mm(3). In all, 62 (52%) and 47 patients (40%) received a combination of 2 nucleoside analogues with efavirenz (EFV) and 1 ritonavir-boosted protease inhibitor (PI/r), respectively. Treatment regimens were in accordance with the guidelines for 114 patients (97%). At 1 year, 16 patients (13.5%) were lost to follow-up, only 5 (4.9%) experienced HIV disease progression or death, but 19 (18.6%) required hospitalization. Antiretroviral therapy was changed in 21 patients (21%). Ten patients (8.4%) experienced virologic failure.

Conclusion: Antiretroviral therapy was in agreement with guidelines for the choice of combination but was often initiated too late.

法国开始抗逆转录病毒治疗:遵守国家指南和结果。
目的和方法:回顾性研究2007年在巴黎单一中心开始抗逆转录病毒治疗(ART)的所有患者,基线特征和1年结局,以评估对国家指南的依从性。结果:我们分析了118例患者。只有64例(54.2%)患者的ART起始时间与指南一致。50名患者(42%)在开始抗逆转录病毒治疗时伴有艾滋病或CD4计数。结论:抗逆转录病毒治疗符合联合用药指南的要求,但往往开始得太晚。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书